

Cover Story
News Analysis
By Matthew Bin Han Ong
The Advanced Research Projects Agency for Health, the centerpiece of the Biden Administration’s war on disease, is designed to be something much more than an ordinary federal bureaucracy.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- At House hearing, Democrats clash with RFK Jr. over “radical obstruction of congressional oversight,” vaccine policies
Rep. Lori Trahan: “People are going to die” - As cancer patients use AI chatbots, dangers lurk—but new safeguards can help